Medicilon y Hengrui Pharma profundizan la colaboración estratégica

Posted on by

-Medicilon y Hengrui Pharma profundizan la colaboración estratégica para apoyar la innovación en ADC, ácidos nucleicos pequeños y fármacos CGT BOSTON, 2 de agosto de 2024 /PRNewswire/ — Recientemente, Shanghai Medicilon Inc. (“Medicilon”) y Jiangsu Hengrui Pharmaceuticals Co., Ltd….

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.